For the professional edge in your day-to-day practice, rely on the most timely, objective reporting on significant developments, trends, and emerging patterns in criminal law today—Criminal Law...
Ohio’s three-drug execution protocol is constitutional, the U.S. Court of Appeals for the Sixth Circuit held Feb. 1.
It’s the latest ruling to uphold the use of the controversial sedative midazolam—which death penalty opponents say doesn’t sufficiently prevent pain—in executions after the U.S. Supreme Court’s 2015 opinion in Glossip v. Gross condoned the practice.
A sharply divided 14-judge Sixth Circuit panel rejected a challenge to the protocol in June 2017, having voting along the partisan lines of the presidents who appointed them. All three Republican-appointed judges who again rejected the challenge this time were in the majority in last year’s decision.
Raymond Tibbetts and Alva Campbell, one of whom was a plaintiff in the June case, tried to halt their upcoming executions by claiming the state’s midazolam-based protocol presents a constitutionally unacceptable risk of pain and suffering.
But none of their new arguments, including that Ohio’s method causes undue psychological pain, show the protocol “presents a risk that is sure or very likely to cause serious pain and needless suffering,” Judge Alice M. Batchelder wrote for the court, upholding the district court’s rejection of their claim.
Nor could the inmates show an available, feasible execution alternative, as required, the court said.
“Tibbets and Campbell bore the burden of proof on this issue and they have produced nothing on appeal to convince us that that the district court was mistaken,” it said.
Judges John M. Rogers and Amul R. Thapar joined the opinion.
The Federal Defender, Columbus, Ohio, represented Tibbetts and Campbell. The Ohio attorney general represented the state.
The case is In re Ohio Execution Protocol Litig. (Campbell v. Kasich) , 2018 BL 33894, 6th Cir., 17-4221, 2/1/18 .
To contact the reporter on this story: Jordan S. Rubin in Washington at email@example.com
To contact the editor responsible for this story: C. Reilly Larson at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)